The Cyprus Oncology Society (OEK) clarified its position on Wednesday regarding the approval of requests for cancer treatment drugs by the Health Insurance Organisation (HIO), amid complains of delays the availability of treatment .
OEK addressed procedural issues and delays linked to the transfer of the nominal requests committee from the Health Ministry to the HIO which took place back in May.
It actively participated in consultations aimed at accelerating
